Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00693420 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence
A Phase 3 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 3
- Development phase
- 278
- Enrollment target
NCT00693420: Completed Phase 3 study, sponsored by Allergan.
NCT00693420 is a Phase 3 study that has completed, run by Allergan. The registered enrollment target is 278 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00693420, a Phase 3 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 278 participants
- Enrollment target
Study Summary
This study evaluates the safety and effectiveness of topical bimatoprost solution for enhancing eyelash prominence.
Primary Outcome
The GEA scale is an investigator-graded 4-point ordinal scale of overall eyelash prominence (1 \[minimal\], 2 \[moderate\], 3 \[marked\], 4 \[very marked\])
Interventions
- DRUG Bimatoprost 0.03% sterile solution
- DRUG vehicle sterile solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 278 participants |
| Start Date | 2007-04 |
| Est. Completion | 2007-12 |
| Phase | Phase 3 |
What the finished NCT00693420 record still lists
NCT00693420 is an interventional study that assigns participants to a tested intervention. The registered 278 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 2 interventions - of which Bimatoprost 0.03% sterile solution is the first listed.
NCT00693420 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00693420 about?
NCT00693420 is a clinical study titled "Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence". This study evaluates the safety and effectiveness of topical bimatoprost solution for enhancing eyelash prominence.
What is the current status of trial NCT00693420?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 278 participants. The study started on 2007-04. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00693420?
The interventions under investigation include: Bimatoprost 0.03% sterile solution (DRUG), vehicle sterile solution (DRUG).
Who is sponsoring clinical trial NCT00693420?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00693420's enrollment target sits among peer trials
278 1200th of 2000 higher than 799 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04586959 · 278 participants · NA
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
- NCT05010148 · 278 participants · Phase 3
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
- NCT05489237 · 278 participants · Phase 1
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
- NCT05965245 · 278 participants · NA
Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia